Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

CMV infection increases the risk of GvHD after bone marrow transplants.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

CD133+ cells are crucial for hair growth.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

CDK4 levels affect the number of hair follicle stem cells in mice.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

T cells show stress responses in alopecia areata, suggesting potential treatment targets.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Impaired regulatory T cells worsen psoriasis, but treatments can help restore balance.

3D spheroid culture makes stem cells better at reducing inflammation.

Prior infections reduced alopecia areata development in mice.

CD200- cells in hair follicles have a higher ability to regenerate hair.

Myeloid cells can turn into skin and hair cells to help heal wounds.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Blocking certain proteins on immune cells may help treat alopecia areata.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Imbalance in immune cells causes hair loss in alopecia areata.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

The assay effectively identifies compounds that affect immune cell activation.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.